Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden · Delayed Price · Currency is SEK 5.95
+0.29 (5.11%)
Mar 20, 2026, 5:29 PM CET
Xbrane Biopharma AB Market Cap
Xbrane Biopharma AB has a market cap or net worth of 122.56 million as of March 20, 2026. Its market cap has decreased by -49.69% in one year.
Market Cap
122.56M
Enterprise Value
94.28M
Revenue
152.35M
Ranking
n/a
PE Ratio
0.96
Stock Price
5.95
Market Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has decreased from 131.05M to 122.56M, a decrease of -6.48%. That is a compound annual growth rate of -0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 122.56M | -41.69% |
| Dec 30, 2025 | 210.17M | -14.54% |
| Dec 30, 2024 | 245.94M | -17.28% |
| Dec 29, 2023 | 297.31M | -86.83% |
| Dec 30, 2022 | 2.26B | -13.94% |
| Dec 30, 2021 | 2.62B | 58.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Magle Chemoswed Holding AB | 170.36M |
| NextCell Pharma AB | 135.01M |
| IRLAB Therapeutics AB | 134.71M |
| Active Biotech AB | 112.03M |
| Simris Group AB (PUBL) | 112.03M |
| Annexin Pharmaceuticals AB | 102.36M |
| Scandinavian ChemoTech AB | 102.32M |
| Alligator Bioscience AB | 98.89M |